BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 28339584)

  • 1. Prosthesis depth and conduction disturbances after last generation balloon-expandable transcatheter aortic valve implantation.
    Iacovelli F; Pignatelli A; Giugliano G; Stabile E; Cicala M; Salemme L; Cioppa A; Popusoi G; Pucciarelli A; Verdoliva S; Bortone AS; Losi MA; Coscioni E; Esposito G; Contegiacomo G; Tesorio T
    Europace; 2018 Jan; 20(1):116-123. PubMed ID: 28339584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement With the SAPIEN 3.
    Mauri V; Reimann A; Stern D; Scherner M; Kuhn E; Rudolph V; Rosenkranz S; Eghbalzadeh K; Friedrichs K; Wahlers T; Baldus S; Madershahian N; Rudolph TK
    JACC Cardiovasc Interv; 2016 Nov; 9(21):2200-2209. PubMed ID: 27832845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the Pacemaker Rate After Transition From Edwards SAPIEN XT to SAPIEN 3 Transcatheter Aortic Valve Implantation: The Critical Role of Valve Implantation Height.
    De Torres-Alba F; Kaleschke G; Diller GP; Vormbrock J; Orwat S; Radke R; Reinke F; Fischer D; Reinecke H; Baumgartner H
    JACC Cardiovasc Interv; 2016 Apr; 9(8):805-813. PubMed ID: 27017367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conduction disturbances and permanent cardiac pacing after transcatheter implantation of the CoreValve aortic bioprosthesis: initial single centre experience.
    Czerwińska K; Hryniewiecki T; Oręziak A; Dąbrowski M; Michałowska I; Witkowski A; Demkow M; Stępińska J; Orłowska Baranowska E; Rużyłło W
    Kardiol Pol; 2012; 70(2):121-8. PubMed ID: 22427074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Highly Predictive Risk Model for Pacemaker Implantation After TAVR.
    Maeno Y; Abramowitz Y; Kawamori H; Kazuno Y; Kubo S; Takahashi N; Mangat G; Okuyama K; Kashif M; Chakravarty T; Nakamura M; Cheng W; Friedman J; Berman D; Makkar RR; Jilaihawi H
    JACC Cardiovasc Imaging; 2017 Oct; 10(10 Pt A):1139-1147. PubMed ID: 28412434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computed tomography (CT) assessment of the membranous septal anatomy prior to transcatheter aortic valve replacement (TAVR) with the balloon-expandable SAPIEN 3 valve.
    Oestreich BA; Mbai M; Gurevich S; Nijjar PS; Adabag S; Bertog S; Kelly R; Garcia S
    Cardiovasc Revasc Med; 2018; 19(5 Pt B):626-631. PubMed ID: 29352699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors and 5-Year Clinical Outcomes of Pacemaker After TAVR: Analysis From the PARTNER 2 SAPIEN 3 Registries.
    Chen S; Dizon JM; Hahn RT; Pibarot P; George I; Zhao Y; Blanke P; Kapadia S; Babaliaros V; Szeto WY; Makkar R; Thourani VH; Webb JG; Mack MJ; Leon MB; Kodali S; Nazif TM
    JACC Cardiovasc Interv; 2024 Jun; 17(11):1325-1336. PubMed ID: 38866455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Outcomes in Patients With New Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement.
    Chamandi C; Barbanti M; Munoz-Garcia A; Latib A; Nombela-Franco L; Gutiérrez-Ibanez E; Veiga-Fernandez G; Cheema AN; Cruz-Gonzalez I; Serra V; Tamburino C; Mangieri A; Colombo A; Jiménez-Quevedo P; Elizaga J; Laughlin G; Lee DH; Garcia Del Blanco B; Rodriguez-Gabella T; Marsal JR; Côté M; Philippon F; Rodés-Cabau J
    JACC Cardiovasc Interv; 2018 Feb; 11(3):301-310. PubMed ID: 29413244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors for permanent pacemaker implantation in patients undergoing transfemoral aortic valve implantation with the Edwards Sapien 3 valve.
    Gonska B; Seeger J; Keßler M; von Keil A; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2017 Aug; 106(8):590-597. PubMed ID: 28283746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of permanent pacemaker implantation after transfemoral aortic valve implantation with the Lotus valve.
    Keßler M; Gonska B; Seeger J; Rottbauer W; Wöhrle J
    Am Heart J; 2017 Oct; 192():57-63. PubMed ID: 28938964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aortic valve and left ventricular outflow tract calcium volume and distribution in transcatheter aortic valve replacement: Influence on the risk of significant paravalvular regurgitation.
    Hansson NC; Leipsic J; Pugliese F; Andersen HR; Rossi A; Simonato M; Jensen KT; Christiansen EH; Terkelsen CJ; Blanke P; Tang M; Krusell LR; Klaaborg KE; Terp K; Kennon S; Dvir D; Bøtker HE; Webb J; Nørgaard BL
    J Cardiovasc Comput Tomogr; 2018; 12(4):290-297. PubMed ID: 29519754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimizing Permanent Pacemaker Following Repositionable Self-Expanding Transcatheter Aortic Valve Replacement.
    Jilaihawi H; Zhao Z; Du R; Staniloae C; Saric M; Neuburger PJ; Querijero M; Vainrib A; Hisamoto K; Ibrahim H; Collins T; Clark E; Pushkar I; Bamira D; Benenstein R; Tariq A; Williams M
    JACC Cardiovasc Interv; 2019 Sep; 12(18):1796-1807. PubMed ID: 31473236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of Onset and Outcome of New Conduction Abnormalities Following Transcatheter Aortic Valve Implantation: Role of Balloon Aortic Valvuloplasty.
    Campelo-Parada F; Nombela-Franco L; Urena M; Regueiro A; Jiménez-Quevedo P; Del Trigo M; Chamandi C; Rodríguez-Gabella T; Auffret V; Abdul-Jawad Altisent O; DeLarochellière R; Paradis JM; Dumont E; Philippon F; Pérez-Castellano N; Puri R; Macaya C; Rodés-Cabau J
    Rev Esp Cardiol (Engl Ed); 2018 Mar; 71(3):162-169. PubMed ID: 28566243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Aortomitral Continuity Calcification on Need for Permanent Pacemaker After Transcatheter Aortic Valve Replacement.
    Katchi F; Bhatt D; Markowitz SM; Szymonifka J; Cheng EP; Minutello RM; Bergman GW; Wong SC; Salemi A; Truong QA
    Circ Cardiovasc Imaging; 2019 Dec; 12(12):e009570. PubMed ID: 31813271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry.
    Nazif TM; Dizon JM; Hahn RT; Xu K; Babaliaros V; Douglas PS; El-Chami MF; Herrmann HC; Mack M; Makkar RR; Miller DC; Pichard A; Tuzcu EM; Szeto WY; Webb JG; Moses JW; Smith CR; Williams MR; Leon MB; Kodali SK;
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):60-9. PubMed ID: 25616819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for permanent pacemaker implantation in patients receiving a balloon-expandable transcatheter aortic valve prosthesis.
    Droppa M; Rudolph TK; Baan J; Nielsen NE; Baumgartner H; Vendrik J; Froehlich M; Borst O; Wöhrle J; Gawaz M; Potratz P; Hack LP; Mauri V; Baranowski J; Bramlage P; Kurucova J; Thoenes M; Rottbauer W; Geisler T
    Heart Vessels; 2020 Dec; 35(12):1735-1745. PubMed ID: 32591894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conduction Abnormalities and Pacemaker Implantations After SAPIEN 3 Vs SAPIEN XT Prosthesis Aortic Valve Implantation.
    Husser O; Kessler T; Burgdorf C; Templin C; Pellegrini C; Schneider S; Kasel AM; Kastrati A; Schunkert H; Hengstenberg C
    Rev Esp Cardiol (Engl Ed); 2016 Feb; 69(2):141-8. PubMed ID: 26542175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conduction dynamics after transcatheter aortic valve implantation and implications for permanent pacemaker implantation and early discharge: the CONDUCT-study.
    van Gils L; Baart S; Kroon H; Rahhab Z; El Faquir N; Rodriguez Olivares R; Aga Y; Maugenest AM; Theuns DA; Boersma E; Szili Torok T; De Jaegere PP; Van Mieghem NM
    Europace; 2018 Dec; 20(12):1981-1988. PubMed ID: 29688322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the repositionable Evolut R CoreValve system on the need for a permanent pacemaker after transcatheter aortic valve implantation in patients with severe aortic stenosis.
    Ojeda S; Hidalgo F; Romero M; Mazuelos F; Suárez de Lezo J; Martín E; Lostalo A; Luque A; González R; Fernández A; López-Aguilera J; Segura J; Guerrero N; Pan M
    Catheter Cardiovasc Interv; 2020 Mar; 95(4):783-790. PubMed ID: 31062927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
    Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
    Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.